Journal ArticleOPEN ACCESS

Comparison of effects of Empagliflozin and Linagliptin on renal function and glycaemic control: a double-blind, randomized clinical trial

  • Mohammad zadeh Gharabaghi M
  • Rezvanfar M
  • Saeedi N
  • et al.
Clinical Diabetes and Endocrinology (2022) 8(1)
DOI: 10.1186/s40842-022-00142-1
N/ACitations
Citations of this article
20Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This study aimed to compare the effects of Linagliptin and Empagliflozin on renal function and glycaemic control in patients with type 2 diabetes mellitus (DM).

Cite

CITATION STYLE

APA

Mohammad zadeh Gharabaghi, M. A., Rezvanfar, M. R., Saeedi, N., Aghajani, F., Alirezaei, M., Yarahmadi, P., & Nakhostin-Ansari, A. (2022). Comparison of effects of Empagliflozin and Linagliptin on renal function and glycaemic control: a double-blind, randomized clinical trial. Clinical Diabetes and Endocrinology, 8(1). https://doi.org/10.1186/s40842-022-00142-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free